Literature DB >> 17072799

Medical complications after lung transplantation.

Selim M Arcasoy1, Jessie Wilt.   

Abstract

Despite remarkable progress in short-term functional and survival outcomes following lung transplantation, long-term outcomes remain limited due to a multitude of medical complications caused predominantly by immunosuppressive protocols. Although chronic allograft rejection and infection account for the majority of deaths beyond the first year after lung transplantation, a large number of other medical problems contribute significantly to excess mortality and morbidity. This article reviews the most frequent and important medical complications of lung transplantation, other than rejection and infection, with an emphasis on complications that involve the respiratory tract.

Entities:  

Mesh:

Year:  2006        PMID: 17072799     DOI: 10.1055/s-2006-954611

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  5 in total

Review 1.  New frontiers in immunosuppression.

Authors:  Luke J Benvenuto; Michaela R Anderson; Selim M Arcasoy
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Defining novel health-related quality of life domains in lung transplantation: a qualitative analysis.

Authors:  Jonathan Paul Singer; Joan Chen; Patricia P Katz; Paul David Blanc; Marjorie Kagawa-Singer; Anita L Stewart
Journal:  Qual Life Res       Date:  2014-12-04       Impact factor: 4.147

3.  Pattern and Predictors of Hospital Readmission During the First Year After Lung Transplantation.

Authors:  M Alrawashdeh; R Zomak; M A Dew; S Sereika; M K Song; J M Pilewski; A DeVito Dabbs
Journal:  Am J Transplant       Date:  2016-10-27       Impact factor: 8.086

4.  Medical Complications of Lung Transplantation.

Authors:  Moo Suk Park
Journal:  J Chest Surg       Date:  2022-08-05

5.  Patient-reported health outcomes in long-term lung transplantation survivors: A prospective cohort study.

Authors:  A Shahabeddin Parizi; P F M Krabbe; E A M Verschuuren; R A S Hoek; J M Kwakkel-van Erp; M E Erasmus; W van der Bij; K M Vermeulen
Journal:  Am J Transplant       Date:  2017-10-12       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.